Publications by authors named "Eirini D Tseligka"

Claim this Profile
V
Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice.
Kuo-Feng Weng, Han Kang Tee, Eirini D Tseligka, Valeria Cagno, Gregory Mathez

Cell Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance.
Diana Gomes, Cyril Sobolewski, Stéphanie Conzelmann, Tifany Schaer, Etienne Lefai, Eirini D Tseligka

Sci Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule libraries.
Eirini D Tseligka, Stéphanie Conzelmann, Yves Cambet, Tifany Schaer, Francesco Negro

JHEP Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDV Pathogenesis: Unravelling Ariadne's Thread.
Eirini D Tseligka, Sophie Clément, Francesco Negro

Viruses· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
Valeria Cagno, Eirini D Tseligka, Samuel T Jones, Caroline Tapparel

Viruses· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium model.
Bernadett Boda, Sacha Benaoudia, Song Huang, Rosy Bonfante, Ludovic Wiszniewski, Eirini D Tseligka

Antiviral Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism.
Eirini D Tseligka, Komla Sobo, Luc Stoppini, Valeria Cagno, Fabien Abdul

PLoS Pathog· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Development of Target-Specific Delocalized Lipophilic Cation-Functionalized Carboranes for Cancer Therapy.
Eirini D Tseligka, Aikaterini Rova, Elsa P Amanatiadou, Gianpiero Calabrese, John Tsibouklis

Pharm Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.
George Makris, Eirini D Tseligka, Ioannis Pirmettis, Minas S Papadopoulos, Ioannis S Vizirianakis

Mol Pharm· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biocompatible Zr-based nanoscale MOFs coated with modified poly(ε-caprolactone) as anticancer drug carriers.
Maria Filippousi, Stuart Turner, Karen Leus, Panoraia I Siafaka, Eirini D Tseligka

Int J Pharm· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis